NEW YORK, March 23, 2012—Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, today announced that Simon Li, General Manager, Kantar Health China, will present at the Pharma China Annual Forum March 30 at the Rendezvous Merry Hotel in Shanghai.
Mr. Li will present “Diabetes in China: Market Characteristics, Trends and Implications” from 14:50 to 15:00. The presentation will explore disease trends of diabetes in China, which has the largest population of diabetics in the world. Most often, pharmaceutical companies measure market share, picture the competitive landscape and understand physician behaviors to guide their strategy. Mr. Li’s presentation tries to bring a “patient-centric” focus to what the key trends of the patients are and how they impact the portfolio, brand value, market access and services on a strategic level. Centered on the high-prevalence, fasting-growing diabetics market, the presentation tells a “whole” story about a disease and its treatment and also presents an example of how to look at the market at a fresh angle. These findings are tied up with key implications to pharmaceutical companies.
With almost two decades of healthcare market research experience in China, Mr. Li has combined his market research expertise and understanding of the China healthcare market to help customers understand and navigate the Chinese regulatory and market environment—and design the research programs to ensure their success in this important region.
Kantar Health has extensive experience in emerging markets. To learn more about diabetes in China, download Kantar Health’s white paper, “The Burden of the Complicated Type 2 Diabetes Patient in China.” For more information on the Pharma China Annual Forum, visit the conference website.
About Kantar Health (www.kantarhealth.com)
Kantar Health is a global, evidence-based decision support partner to the world’s leading pharmaceutical, biotech, device and diagnostic companies. Our 700+ staff act as catalysts, working closely with customers to drive distinctive decision-making that helps them prioritize product development and portfolios, differentiate their brands and ensure product profitability after launch. We are unique in that we bring together clinical, medical and methodological expertise, commercial/marketing know-how and proprietary data. It is this rare combination, together with our unparalleled stakeholder reach, that enables us to mobilize incisive, imaginative and timely ROI-driven solutions, empowering clients to deliver better healthcare options to their customers.
With offices in over 40 countries, we excel at solving technically or logistically challenging projects around the world and across the product lifecycle, combining on-the-ground know-how and global and national proprietary data to quickly identify value drivers. As part of WPP, we can also incorporate highly innovative thinking from outside the industry into our solutions.
For more information on Kantar Health, please contact Paula Paradise, Vice President of Global Marketing, at firstname.lastname@example.org or +1-484-442-1431.